IGF1 and Alzheimer disease: Additionally, C/EBPβ, a transcription factor activated in AD microglia, disrupts IGF-1 signaling and increases inflammation through the production of pro-inflammatory molecules derived from arachidonic acid, which may accelerate neurodegeneration [131].